Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HYPERION THERAPEUTICS INC (HPTX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-15 | Dec-31-14 | Sep-30-14 | Jun-30-14 | Mar-31-14 | Dec-31-13 | Sep-30-13 | Jun-30-13 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 13.7% | 13.8% | 13.4% | 15.1% | 16.8% | 19.1% | 7.5% | 2.6% |
| Gross profit | 86.3% | 86.2% | 86.6% | 84.9% | 83.2% | 80.9% | 92.5% | 97.4% |
| Selling, general and administrative | 47.1% | 48.9% | 48.6% | 49.2% | 72.3% | 101.4% | 58.2% | 65.8% |
| Research and development | 34.7% | 35.2% | 25.7% | 23.5% | 33.7% | 47.7% | 18.9% | 26.6% |
| EBITDA | 34.0% | 35.1% | 29.0% | 31.0% | 5.6% | -25.0% | -39.5% | -72.9% |
| Depreciation | 0.5% | 0.5% | 0.5% | 0.4% | 0.5% | 0.6% | 0.2% | 0.2% |
| EBITA | 33.6% | 34.6% | 28.5% | 30.6% | 5.1% | -25.6% | -39.6% | -73.1% |
| Amortization of intangibles | 8.1% | 9.2% | 8.0% | 8.5% | 10.0% | 12.4% | 2.5% | 0.9% |
| EBIT | 25.5% | 25.5% | 20.6% | 22.1% | -4.9% | -38.0% | -42.2% | -73.9% |
| Pre-tax income | 0.7% | -6.7% | -13.3% | 20.7% | 50.0% | 47.2% | 15.0% | 7.7% |
| Income taxes | 1.6% | 0.3% | 1.1% | -2.4% | 0.3% | 0.1% | 0.0% | 0.0% |
| Net income | -0.9% | -7.0% | -14.4% | 23.0% | 49.7% | 47.1% | 15.0% | 7.7% |
|